How to Improve Clinical Trials by Empowering the Patient to Share their RWD and Patient-Contributed Data
In the rapidly evolving world of clinical trial technology, Debi Willis, CEO of MyPatientLink, is leading the charge in...
Unbuzzd™ Clinical Trial Success Announced by Quantum Biopharma
Quantum BioPharma Ltd. announced positive results from a clinical trial of its dietary supplement, unbuzzd™, demonstrating its efficacy in...
GlucoTrack Announces Successful Human Clinical Trial of CGM
Glucotrack, Inc. has successfully completed its first human clinical study of a continuous blood glucose monitor (CBGM) implanted in...
10 Bold Solutions to End Cancer: City of Hope’s Plan
City of Hope, a leading cancer research and treatment organization, has outlined strategies to combat rising cancer rates, particularly...
FDA Approves Susvimo for Diabetic Blindness
The FDA approved Susvimo (ranibizumab injection) for diabetic macular edema (DME), a leading cause of vision loss. This marks...
Auron Therapeutics Announces FDA Clearance and Series B Financing
Auron Therapeutics, a clinical-stage biotech company, announced progress on its lead KAT2A/B program and candidate AUTX-703, along with a...
FLT201 Gene Therapy Shows Promise in Gaucher Disease Trial
Spur Therapeutics released positive Phase 1/2 trial data for FLT201, a gene therapy for Gaucher disease type 1. The...
SiteOne Announces Positive Phase 1 Data for Novel Non-Opioid Pain Drug
SiteOne Therapeutics announced positive Phase 1 clinical trial results for STC-004, its lead NaV1.8 inhibitor for non-opioid pain treatment....
Aclaris Announces Fully Funded Clarity Trial for Nociscan
Aclarion, Inc. (Nasdaq: ACON, ACONW) has secured approximately $20 million to fully fund its pivotal CLARITY trial. This trial...
CD47 Inhibitor Drugs Market 2028: 100+ Clinical Trials & Opportunities
The report “Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028” explores the burgeoning field of...